Megalabs-Pharma S.A. is a pharmaceutical company headquartered in Quito, Ecuador, operating in the drugs and druggists' sundries merchant wholesale industry. It is part of Grupo Megalabs, a regional pharmaceutical conglomerate specializing in the production and distribution of a wide range of medications across manufacturing and distribution segments. The company employs approximately 315 people and reported net sales revenue growth of 19.21% in 2025. It is dedicated to providing high-quality, safe, reliable, and accessible medicines, aligned with Grupo Megalabs' regional operations across 18 countries in Latin America and the Caribbean.
| Import | Export |
|---|---|
|
Trade Records
2861
|
Trade Records
29
|
|
Suppliers
65
|
Buyers
9
|
|
Latest Import Date
2026-07
|
Latest Export Date
2026-07
|
According to Topease's global trade data, MEGALABS-PHARMA S.A. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the MEGALABS-PHARMA S.A. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, MEGALABS-PHARMA S.A. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore MEGALABS-PHARMA S.A.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| MEGA LABS S A XC O DISTRI TRANSPHARMAR S A | MEGALABS-PHARMA S.A. | 3002 | 24 | $186,500 | 3,420 | Los Angeles |
| MEGALABS COLOMBIA SAS PARQUE | MEGALABS-PHARMA S.A. | 2106 | 24 | $186,500 | 3,420 | Los Angeles |
| LABORATORIOS ROWE SRL | MEGALABS-PHARMA S.A. | 2106 | 24 | $186,500 | 3,420 | Los Angeles |
| ICLOS URUGUAY SA POR CUENTA Y ORDEN DE DROMEX INTE | MEGALABS-PHARMA S.A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| LOTUS PHARMACEUTICAL LTD CO | MEGALABS-PHARMA S.A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into MEGALABS-PHARMA S.A.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| MEGA LABS LATAM S.A. | MEGALABS-PHARMA S.A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| LETERAGO S.A. | MEGALABS-PHARMA S.A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| MEGA LABS S A XC O DISTRI TRANSPHARMAR S A | MEGALABS-PHARMA S.A. | 3002 | 24 | $186,500 | 3,420 | Los Angeles |
| DISTRIBUIDORA LETERAGO,S.A. | MEGALABS-PHARMA S.A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| SOLUCIONES Y SOPORTES TECNICOS S.A.C. S Y ST S.A.C. | MEGALABS-PHARMA S.A. | 9013 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore MEGALABS-PHARMA S.A.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access MEGALABS-PHARMA S.A.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.